Pionyr Immunotherapeutics Stock

www.pionyrtx.comHealthcareFounded: 2015

Pionyr Immunotherapeutics develops cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity and ability to combat cancer.

Register for Details

For more details on financing and valuation for Pionyr Immunotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Pionyr Immunotherapeutics.

Register Today

Other companies like Pionyr Immunotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B